Immune checkpoint inhibitor resistance in dMMR high-grade intraepithelial neoplasia with lynch syndrome-associated colon cancer: a case report

Authors:

Abstract
Immune checkpoint inhibitors demonstrate high efficacy in MSI-H/dMMR colorectal cancer, yet a subset of patients develops resistance. This case reports in
Funding Information
  • the Natural Science Foundation of Jiangxi Province (20242BAB26146)
  • National Natural Science Foundation of China (82160464)
  • the “Double Thousand” project for training high-level talents of scientific and technological innovation in Jiangxi Province (jxsq2023201038)